Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,900.00p
   
  • Change Today:
      25.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,350.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 22,297
  • Market Cap: £151.52m

Latest ShareCast News

Revenue rises, profit falls for Bioventix

By Josh White

Date: Monday 31 Mar 2025

(Sharecast News) - Bioventix reported a marginal rise in revenue for the six months ended 31 December on Monday, with profit before tax dipping slightly due to higher research and development expenditure.

Director dealings: Bioventix CFO raises stake

By Iain Gilbert

Date: Thursday 31 Oct 2024

(Sharecast News) - Bioventix revealed on Thursday that chief financial officer Bruce Hiscock had acquired 333 ordinary shares in the London-listed antibodies development and supply company.

BioVentix reports year of growth, warns of geopolitical risks

By Josh White

Date: Monday 28 Oct 2024

(Sharecast News) - BioVentix, a UK-based developer of high-affinity monoclonal antibodies for clinical diagnostics, reported a 6% improvement in full-year revenue on Monday, to £13.6m, up from £12.82m in the prior year.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,900.00p
Change Today 25.00p
% Change 0.87 %
52 Week High 4,500.00
52 Week Low 2,350.00
Volume 22,297
Shares Issued 5.22m
Market Cap £151.52m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
25.27% below the market average25.27% below the market average25.27% below the market average25.27% below the market average25.27% below the market average
31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average
Price Trend
59.87% below the market average59.87% below the market average59.87% below the market average59.87% below the market average59.87% below the market average
14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average
Income
39.70% above the market average39.70% above the market average39.70% above the market average39.70% above the market average39.70% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
15.38% below the market average15.38% below the market average15.38% below the market average15.38% below the market average15.38% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 23-May-2025

Time Volume / Share Price
10:03 8,758 @ 2,890.00p
09:47 7,500 @ 2,875.00p
16:03 24 @ 2,850.00p
12:05 200 @ 2,920.00p
10:04 2,500 @ 2,875.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page